CXCL8 is upregulated in many cancers including solid tumors (brain, breast, colon, gastric, lung, and others) and blood cancers (AML, CLL, Hodgkin’s lymphoma) and high levels of CXCL8 expression are often linked with disease progression (11). This evidence concerns the gene CXCL8 and hematopoietic and lymphoid system neoplasm.